医薬品における卵タンパク質の世界市場規模、シェア、トレンド分析レポート – 業界概要と2031年までの予測

医薬品市場における卵タンパク質の分析と規模

医薬品における卵タンパク質市場は、そのユニークな機能特性と高い栄養価により、大幅な成長を遂げています。この市場は、薬物製剤および生物製剤における高品質のタンパク質源の需要増加の恩恵を受けています。卵タンパク質は、効果的な安定剤、乳化剤、およびキャリアとして機能するため、医薬化合物の溶解性と生物学的利用能が向上し、その採用が促進されています。さらに、特にインフルエンザやその他のウイルスワクチンのワクチン製造における卵タンパク質の使用は、市場の拡大をさらに後押ししています。医療費の増加、製薬技術の進歩、効果的な薬物送達システムへの注目の高まりなどの要因が、市場のプラス軌道に貢献しています。   

医薬品市場における卵タンパク質の規模

医薬品に使用される卵タンパク質の世界市場規模は、2023年に36億6,000万米ドルと評価され、2024年から2031年の予測期間中に6.50%のCAGRで成長し、2031年までに60億6,000万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家の分析、地理的に表された企業別の生産と生産能力、販売業者とパートナーのネットワークレイアウト、詳細で最新の価格動向分析、サプライチェーンと需要の不足分析も含まれています。

レポートの範囲と市場セグメンテーション       

Egg Protein in Pharmaceuticals Market Definition

Egg protein in pharmaceuticals refers to the use of proteins derived from eggs, particularly egg whites, in the development and formulation of pharmaceutical products. Egg proteins, known for their high biological value and rich amino acid profile, are utilized for their functional and nutritional properties. In pharmaceuticals, egg proteins are often used as stabilizers, emulsifiers, and carriers in drug formulations. Their ability to enhance the solubility and bioavailability of certain drugs makes them valuable in improving the efficacy of pharmaceutical products.                 

Egg Protein in Pharmaceuticals Market Dynamics

Drivers

• Effective Stabilization and Emulsification of Egg Proteins   

Egg proteins are renowned for their superior stabilizing and emulsifying properties, which make them highly valuable in pharmaceutical applications. In drug formulations, egg proteins function as excellent stabilizers, maintaining the consistency and quality of the product by preventing the separation of ingredients. They also serve as effective emulsifiers, ensuring the uniform dispersion of immiscible substances such as oils and water. This capability is particularly crucial in complex formulations where precise consistency is essential for efficacy. By enhancing the stability and homogeneity of pharmaceutical products, egg proteins contribute to improved drug delivery systems and overall product performance, driving market growth.   

• Growing Demand for Vaccines     

Egg proteins play a pivotal role in the manufacturing of various vaccines, including those for influenza and other viral infections, where they serve as a medium for the growth of vaccine antigens. The ability of egg proteins to support the cultivation of these antigens ensures the effectiveness and safety of the vaccines. As the global need for biologics continues to rise due to the prevalence of infectious diseases and the expansion of vaccination programs, egg proteins remain integral to the production process. This growing demand for biologics and vaccines thus drives the market for egg proteins. 

Opportunities

• Advancements in Pharmaceutical Technologies  

New technologies, such as targeted drug delivery systems and novel formulations, often require specialized stabilizers and emulsifiers to enhance their performance and effectiveness. Egg proteins, with their unique functional properties, are well-suited for these advanced applications. As pharmaceutical companies seek to develop more efficient and effective drug delivery solutions, the demand for egg proteins is expected to rise. Innovations in pharmaceutical technologies, including advanced drug delivery systems and formulations, have created significant opportunities for the use of egg proteins.    

• Rising Healthcare Expenditure    

With healthcare budgets expanding and spending on pharmaceuticals rising, there is a greater emphasis on developing high-quality and effective drug formulations. Egg proteins, known for their superior stabilizing and emulsifying properties, are increasingly being utilized to meet these demands. This rise in healthcare expenditure supports the investment in advanced pharmaceutical products and technologies, further driving the market for egg proteins. As healthcare priorities continue to evolve and expand, the role of egg proteins in ensuring the quality and efficacy of pharmaceutical products becomes increasingly prominent. The increasing global expenditure on healthcare and pharmaceuticals is creating growth opportunities for the egg protein market.    

Top of Form

Restraints/Challenges

• Availability of Alternative Proteins  

The availability of alternative proteins and stabilizers poses a challenge to the reliance on egg proteins in pharmaceuticals. With the growing interest in plant-based and synthetic alternatives, pharmaceutical companies have more options for stabilizers and emulsifiers that may offer similar or improved functionalities without the potential drawbacks associated with egg proteins. These alternatives can provide solutions for those with allergies or dietary restrictions and may be perceived as more sustainable or cost-effective. As the market for alternative ingredients expands, the demand for egg proteins may be affected, challenging the market growth.        

• Allergies to Egg Proteins

Allergies to egg proteins present a significant challenge in the widespread use of these proteins in pharmaceuticals. For individuals with egg allergies, exposure to egg proteins can trigger adverse reactions, which limits their suitability in drug formulations. This constraint necessitates careful consideration and labeling of pharmaceutical products to ensure the safety of consumers. The presence of egg proteins in medications must be managed to avoid allergic reactions, thereby impacting their broader adoption in the market. As a result, the prevalence of egg allergies can restrict the use of egg proteins, affecting their market potential and prompting the exploration of alternative ingredients.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

• In June 2024, U.S. biotech company The EVERY Co. announced a partnership with Canada’s Landish Foods, a leader in nutritional wellness products in North America. Together, they are launching FERMY, a new range of ready-to-mix protein powders for beverages that feature egg white protein derived from precision fermentation
• In December 2023, ingredient innovator EVERY introduced its flagship product, EVERY Egg, the world's first liquid egg made without hens. Created through yeast fermentation, EVERY Egg was launched after nine years of product development by EVERY

Egg Protein in Pharmaceuticals Market Scope

The market is segmented on the basis of type, flavors, form, function, application, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Egg White Powder
• Egg Yolk Powder
• Whole Egg Protein

Flavors

• Flavoured
• Regular

Form

• Solid
• Liquid
• Powder

Function

• Binding
• Crystallization
• Emulsifying
• Leavening
• Preservatives
• Thickening

Application

• Bakery and Confectionery
• Dietary Supplements
• Feed
• Food and Beverages
• Ice Cream
• Meat Products
• Personal Care and Cosmetics
• Protein and Nutritional Bars

Distribution Channel

• Convenience Stores
• Medical and Drug Stores
• Online Store
• Supermarkets/Hypermarkets

Egg Protein in Pharmaceuticals Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, type, flavors, form, function, application, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the growing consumption of protein supplements and an increase in the production of egg protein. The high demand for protein-rich products, coupled with advancements in production technology and infrastructure, supports North America's market leadership. 

Asia-Pacific is expected to show significant growth due to the expanding presence of various market players and the rapid development of industrial capabilities in these countries. Increasing awareness of health and nutrition, coupled with rising disposable incomes, is driving demand for egg protein-based pharmaceuticals.

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、個々の国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、地域ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税の影響、貿易ルートも考慮されます。

医薬品市場における卵タンパク質のシェア分析

市場競争環境は、競合他社の詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、地域的プレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などが含まれます。提供されている上記のデータ ポイントは、市場における会社の重点にのみ関連しています。

市場で活動している主要な市場プレーヤーの一部は次のとおりです。

• イートジャスト社（米国）
• インテグリカルチャー株式会社（日本）
• アレフファーム（イスラエル）
• AVANTMEATS（中国）
• ビリーバーミーツ（米国）
• newprotein (アルゼンチン)
• バイオフードシステムズ社（イスラエル）
• Meatable（オランダ）
• ミッションバーンズ（米国）
• BlueNalu（米国）
• シンプルフーズ社（米国）
• シオックミーツ（シンガポール）
• CUBIQ FOODS SL（スペイン）

SKU-56731